Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
atazanavir (reyataz) (1 trial)
bictegravir (Biktarvy) (1 trial)
cobicistat (stribild) (1 trial)
elvitegravir (vitekta) (1 trial)
emtricitabine (emtriva) (5 trials)
raltegravir (isentress) (1 trial)
ritonavir (Norvir) (1 trial)
tenofovir (viread) (7 trials)
saavi dna-c2 vaccine (1 trial)
saavi mva-c vaccine (1 trial)
fish oil (Omegavan) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
HIV Infections (Phase 4)
Substance-Related Disorders (Phase 4)
Trials (10 total)
Trial APIs (11 total)